Crawford, J <br/><br/>
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy.  [electronic resource] 

 -  Cytokines, cellular & molecular therapy  Dec 1999 
 - 187-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1368-4736 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Small Cell--drug therapy<br/>Cyclophosphamide--adverse effects<br/>Doxorubicin--adverse effects<br/>Etoposide--adverse effects<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mouth Mucosa--drug effects<br/>Necrosis<br/>Neutropenia--chemically induced<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Recombinant Proteins<br/>Stomatitis--chemically induced<br/>Survival Analysis